Evidence map›Paper›PMID 24816923›Full record

ArticlePloS one2014

Analysis of the effects of five factors relevant to in vitro chondrogenesis of human mesenchymal stem cells using factorial design and high throughput mRNA-profiling.

Rune B Jakobsen, Esben Østrup, Xiaolan Zhang, Tarjei S Mikkelsen, Jan E Brinchmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The Interaction between Joint Inflammation and Cartilage Repair.Tissue engineering and regenerative medicine · 2019
    Review
  12. Review
  13. Role of dexamethasone in the long-term functional maturation of MSC-laden hyaluronic acid hydrogels for cartilage tissue engineering.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Rune B JakobsenNorwegian Center for Stem Cell Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Department of Biochemistry, Institute of Basic Medical Sciences, The Medical Faculty, University of Oslo, Oslo, Norway.
Esben ØstrupNorwegian Center for Stem Cell Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Department of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.
Xiaolan ZhangBroad Institute, Cambridge, Massachusetts, United States of America.
Tarjei S MikkelsenBroad Institute, Cambridge, Massachusetts, United States of America; Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, United States of America.
Jan E BrinchmannNorwegian Center for Stem Cell Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Department of Biochemistry, Institute of Basic Medical Sciences, The Medical Faculty, University of Oslo, Oslo, Norway; Institute of Immunology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Broad Institute · USUniversity of Oslo · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The in vitro process of chondrogenic differentiation of mesenchymal stem cells for tissue engineering has been shown to require three-dimensional culture along with the addition of differentiation factors to the culture medium. In general, this leads to a phenotype lacking some of the cardinal features of native articular chondrocytes and their extracellular matrix. The factors used vary, but regularly include members of the transforming growth factor β superfamily and dexamethasone, sometimes in conjunction with fibroblast growth factor 2 and insulin-like growth factor 1, however the use of soluble factors to induce chondrogenesis has largely been studied on a single factor basis. In the present study we combined a factorial quality-by-design experiment with high-throughput mRNA profiling of a customized chondrogenesis related gene set as a tool to study in vitro chondrogenesis of human bone marrow derived mesenchymal stem cells in alginate. 48 different conditions of transforming growth factor β 1, 2 and 3, bone morphogenetic protein 2, 4 and 6, dexamethasone, insulin-like growth factor 1, fibroblast growth factor 2 and cell seeding density were included in the experiment. The analysis revealed that the best of the tested differentiation cocktails included transforming growth factor β 1 and dexamethasone. Dexamethasone acted in synergy with transforming growth factor β 1 by increasing many chondrogenic markers while directly downregulating expression of the pro-osteogenic gene osteocalcin. However, all factors beneficial to the expression of desirable hyaline cartilage markers also induced undesirable molecules, indicating that perfect chondrogenic differentiation is not achievable with the current differentiation protocols.

Indexed as

Bone Morphogenetic Protein 2Cell Culture TechniquesCell DifferentiationCells, CulturedChondrogenesisCluster AnalysisCulture MediaDexamethasoneDrug InteractionsFibroblast Growth Factor 2Gene Expression ProfilingHumansInsulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsPrincipal Component AnalysisBone Morphogenetic Protein 2Culture MediaDexamethasoneFibroblast Growth Factor 2Insulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsRNA, MessengerTransforming Growth Factor beta

Identifiers

PMID24816923
PMCPMC4015996
OpenAlexW2135234322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.